CARBOPLATIN\PACLITAXEL: 74 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
74
Total FAERS Reports
9 (12.2%)
Deaths Reported
18
Hospitalizations
74
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
First Report: 2011 · Latest Report: 20250101
What Are the Most Common CARBOPLATIN\PACLITAXEL Side Effects?
#1 Most Reported
Neuropathy peripheral
6 reports (8.1%)
#2 Most Reported
Product use in unapproved indication
5 reports (6.8%)
#3 Most Reported
Off label use
5 reports (6.8%)
All CARBOPLATIN\PACLITAXEL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Neuropathy peripheral | 6 | 8.1% | 0 | 0 |
| Drug ineffective | 5 | 6.8% | 2 | 0 |
| Fatigue | 5 | 6.8% | 1 | 2 |
| Malignant neoplasm progression | 5 | 6.8% | 0 | 1 |
| Nausea | 5 | 6.8% | 0 | 3 |
| Off label use | 5 | 6.8% | 0 | 0 |
| Product use in unapproved indication | 5 | 6.8% | 0 | 3 |
Who Reports CARBOPLATIN\PACLITAXEL Side Effects? Age & Gender Data
Gender: 78.1% female, 21.9% male. Average age: 56.7 years. Most reports from: US. View detailed demographics →
Is CARBOPLATIN\PACLITAXEL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 0 |
| 2013 | 1 | 0 | 1 |
| 2016 | 3 | 1 | 1 |
| 2017 | 2 | 1 | 0 |
| 2018 | 2 | 0 | 1 |
| 2019 | 2 | 0 | 1 |
| 2020 | 3 | 0 | 2 |
| 2022 | 3 | 0 | 0 |
| 2023 | 3 | 2 | 1 |
| 2024 | 6 | 1 | 3 |
| 2025 | 1 | 0 | 0 |
What Is CARBOPLATIN\PACLITAXEL Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 11 |
| Triple negative breast cancer | 10 |
| Endometrial cancer | 9 |
| Ovarian cancer | 6 |
Official FDA Label for CARBOPLATIN\PACLITAXEL
Official prescribing information from the FDA-approved drug label.